Cenci, Tonia
 Distribuzione geografica
Continente #
NA - Nord America 4.968
EU - Europa 3.374
AS - Asia 3.121
SA - Sud America 531
Continente sconosciuto - Info sul continente non disponibili 121
AF - Africa 91
OC - Oceania 7
Totale 12.213
Nazione #
US - Stati Uniti d'America 4.841
DE - Germania 1.346
SG - Singapore 1.249
CN - Cina 1.048
SE - Svezia 514
BR - Brasile 433
IT - Italia 364
VN - Vietnam 239
FR - Francia 237
UA - Ucraina 218
GB - Regno Unito 168
IE - Irlanda 132
IN - India 116
PL - Polonia 106
ID - Indonesia 87
FI - Finlandia 82
RU - Federazione Russa 61
TR - Turchia 61
JP - Giappone 56
BD - Bangladesh 54
HK - Hong Kong 51
CA - Canada 46
MX - Messico 43
IQ - Iraq 34
AR - Argentina 32
NL - Olanda 29
ZA - Sudafrica 28
ES - Italia 25
BE - Belgio 20
EC - Ecuador 17
IR - Iran 15
LT - Lituania 15
AT - Austria 14
MA - Marocco 13
SA - Arabia Saudita 13
VE - Venezuela 13
CI - Costa d'Avorio 12
CO - Colombia 12
JM - Giamaica 12
PK - Pakistan 12
KR - Corea 11
TN - Tunisia 9
CL - Cile 8
UZ - Uzbekistan 8
CH - Svizzera 7
NP - Nepal 7
PH - Filippine 7
AZ - Azerbaigian 6
CR - Costa Rica 6
DZ - Algeria 6
KE - Kenya 6
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EG - Egitto 4
ET - Etiopia 4
EU - Europa 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
RO - Romania 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
GE - Georgia 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MY - Malesia 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
VG - Isole Vergini Britanniche 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
Totale 12.082
Città #
Ashburn 927
Singapore 701
Chandler 494
San Jose 384
Hangzhou 314
Beijing 186
Jacksonville 134
Dublin 133
Los Angeles 121
San Mateo 107
New York 102
Nanjing 100
Nürnberg 92
Ho Chi Minh City 87
Warsaw 87
Wilmington 84
Ann Arbor 83
Jakarta 75
Lauterbourg 74
Woodbridge 71
The Dalles 69
Houston 68
Dearborn 61
Seattle 58
Fairfield 57
Hanoi 50
Cattolica 49
Chicago 49
Munich 49
Izmir 47
Rome 47
Frankfurt am Main 46
Hong Kong 46
Milan 45
Tokyo 45
Nanchang 42
Boston 41
Council Bluffs 38
Helsinki 36
Moscow 36
Hefei 35
Lawrence 35
Princeton 33
São Paulo 33
Bremen 29
Hyderabad 29
Redwood City 29
Santa Clara 29
Kunming 26
Orem 25
Redmond 25
Marseille 24
Shanghai 23
Atlanta 22
Dallas 22
Stockholm 22
Paris 20
Buffalo 19
Lancaster 19
Shenyang 19
Denver 18
Mountain View 18
Phoenix 18
Brussels 17
Johannesburg 16
Brooklyn 15
Cambridge 15
Guangzhou 15
Hebei 15
London 15
Baghdad 14
Boardman 14
Memphis 14
Norwalk 14
Tianjin 14
Jiaxing 13
Rio de Janeiro 13
Abidjan 12
Changsha 12
Naples 12
Porto Alegre 12
Toronto 12
Haiphong 11
Kraków 11
Leawood 11
Nuremberg 11
Poplar 11
San Francisco 11
Seoul 11
Augusta 10
Dhaka 10
Kent 10
Manchester 10
Montreal 10
Zhengzhou 10
Amsterdam 9
Chennai 9
Detroit 9
Düsseldorf 9
Fremont 9
Totale 6.353
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 623
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 515
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 404
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 335
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 308
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 273
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study 262
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 260
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 241
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 221
Von hippel-lindau disease and erythrocytosis 218
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 197
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 190
PDGFRA-mutant syndrome 190
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 188
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 182
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 178
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 177
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 174
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 168
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 168
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 168
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 155
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 155
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 154
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 152
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 150
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 150
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 148
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression 146
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 145
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 145
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 145
Methylation study of the Paris system for reporting urinary (TPS) categories 145
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 145
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 144
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 138
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 138
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 136
Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis 135
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights 135
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms 135
The mutant JAK2 allele burden in children with essential thrombocythemia 134
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2 130
Divergent gastrointestinal stromal tumors in syndromic settings 129
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 129
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 125
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 124
Telomerase inhibition in malignant gliomas. A systematic review 123
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 122
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis 122
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 121
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis 121
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach 119
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 118
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases 116
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 112
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 112
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 109
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report 109
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 109
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 107
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 106
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme 105
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 104
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia 104
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 104
Erratum: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells (Nature (2010) 468 (824-828)) 99
To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 99
The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature 99
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 91
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 85
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 79
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 77
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 72
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 62
Totale 12.213
Categoria #
all - tutte 46.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022533 0 0 0 64 57 20 16 96 28 45 87 120
2022/20231.344 196 198 101 208 93 159 54 85 155 28 47 20
2023/20241.116 27 203 25 50 16 92 265 261 6 30 65 76
2024/20251.277 32 29 119 40 106 51 44 55 179 145 255 222
2025/20263.559 490 121 193 432 660 191 659 171 236 231 111 64
2026/2027781 121 436 212 12 0 0 0 0 0 0 0 0
Totale 12.213